Cite Filings / MCRB
Feed Companies Filings Check
Sign in

CIK 0001609809 · Non-accelerated filer<br>Smaller reporting company

Seres Therapeutics, Inc.

Sign in to watch
Ticker
MCRB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
274326290
Phone
617 945 9626
Business address
200 SIDNEY STREET, CAMBRIDGE, MA, 02139
Former names
Seres Therapeutics, Inc., Seres Health, Inc.
Filings Insiders Search text
All 724 Financials 168 Shareholder Meetings 14 Executive Compensation 144 Insider Trading 376 Beneficial Ownership Interest 75 Business Combinations 124 Public Offerings 39 Mutual Funds and ETFs 11 Others 61
›
Filed in
  1. No filings match these filters. Clear filters
  2. DEF 14A Proxy Proxy Statement 2026-04-27
  3. DEF 14A Proxy Proxy Statement 2025-03-13
  4. PRE 14A Proxy Proxy Statement (Preliminary) 2025-03-03
  5. DEF 14A Proxy Proxy Statement 2024-03-05
  6. PRE 14A Proxy Proxy Statement (Preliminary) 2024-02-23
  7. DEF 14A Proxy Proxy Statement 2023-04-25
  8. PRE 14A Proxy Proxy Statement (Preliminary) 2023-04-14
  9. DEF 14A Proxy Proxy Statement 2022-04-29
  10. DEF 14A Proxy Proxy Statement 2021-04-30
  11. DEF 14A Proxy Proxy Statement 2020-04-30
  12. DEF 14A Proxy Proxy Statement 2019-04-30
  13. DEF 14A Proxy Proxy Statement 2018-04-30
  14. DEF 14A Proxy Proxy Statement 2017-05-01
  15. DEF 14A Proxy Proxy Statement 2016-04-28

Page 1 of 1 · 14 filings

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…